UPDATE : Monday, September 7, 2020
상단여백
Biopharma stocks listed in H1 perform poorer than non-pharma peers
Pharmaceutical and biotech companies listed in the first half marked a slow...
by Nam Doo-hyun  |  2018-07-03 15:08
라인
‘Government support for dementia tests might be ill-timed’
The Moon Jae-in administration has vowed to boost support for state dementi...
by Nam Doo-hyun  |  2018-07-03 11:47
라인
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’
Eliquis (ingredient: apixaban) by Bristol-Myers Squibb Korea and Korea Pfiz...
by Nam Doo-hyun  |  2018-07-02 16:47
라인
BMS Korea wins fight for Eliquis patent
Bristol-Myers Squibb (BMS) Korea said it has won a suit against domestic dr...
by Nam Doo-hyun  |  2018-06-29 14:41
라인
Prognostic marker for childhood obesity complications wins patent
A new biomarker in urine to predict childhood obesity complications might b...
by Nam Doo-hyun  |  2018-06-27 12:19
라인
Antarctic sea microorganisms; a solution to blood shortage?
The Korean government has developed a technology to freeze human blood usin...
by Nam Doo-hyun  |  2018-06-26 14:44
라인
Korea’s drug exports to US, Europe on the rise
Korea’s pharmaceutical exports to the U.S. and Europe have expanded over th...
by Nam Doo-hyun  |  2018-06-25 16:09
라인
Chong Kun Dang topped in H1 clinical trial
Chong Kung Dang, a local pharmaceutical firm, beat multinational rivals by ...
by Nam Doo-hyun  |  2018-06-21 11:11
라인
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit
More than 60 percent of biotech companies listed on KOSDAQ suffered operati...
by Nam Doo-hyun  |  2018-06-19 11:43
라인
‘Medytox botulinum toxin worth 600 billion won in China’
Neuronox, the botulinum toxin developed by Medytox that is seeking China’s ...
by Nam Doo-hyun  |  2018-06-19 09:26
라인
Will SGLT-2 inhibitors win more antidiabetic prescriptions?
The pharmaceutical industry is actively discussing merits of sodium-glucose...
by Nam Doo-hyun  |  2018-06-15 11:58
라인
Highlights of US cancer meet: immunotherapy, gastrointestinal cancer
Immunotherapies and gastrointestinal cancer drew the most attention during ...
by Nam Doo-hyun  |  2018-06-14 15:51
라인
Dongkook, Chong Kun Dang most popular in functional foods
Dongkook Pharmaceutical, Chong Kung Dang Healthcare, and Sanofi-Aventis Kor...
by Nam Doo-hyun  |  2018-06-12 11:19
라인
Drugmakers unveil new clinical data at US cancer meet
Korean and global pharmaceutical companies disclosed their newest clinical ...
by Nam Doo-hyun  |  2018-06-08 14:41
라인
Gilead successfully switches HIV drug to Genvoya
Gilead Sciences Korea seems to have successfully switched its key drug in H...
by Nam Doo-hyun  |  2018-06-07 15:11
라인
‘Tug-of-war in Lipiodol pricing only hurts patients’
Guerbet Korea has recently come under fire for threatening to stop the supp...
by Nam Doo-hyun  |  2018-06-05 15:23
라인
‘Baxter’s Theranova dialyzer better than conventional devices’
Baxter’s Theranova, a blood filter for artificial kidneys, can be more effe...
by Nam Doo-hyun  |  2018-05-30 14:29
라인
Korea to review cost-effectiveness of PCV of Pfizer, GSK
The health authorities said they would start analyzing the cost-effectivene...
by Nam Doo-hyun  |  2018-05-25 15:59
라인
Korea exported drugs to Europe the most in first 4 months
Korea exported pharmaceutical products to Europe the most and medical devic...
by Nam Doo-hyun  |  2018-05-24 15:31
라인
Reyon’s suit against ViroMed dismissed over VM202 rights
A recent court decision took a massive blow to Reyon Pharmaceutical, which ...
by Nam Doo-hyun  |  2018-05-24 11:38
-12345678910-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top